401 Episodo

  1. Episode 83: Is cabozantinib the new standard of care in papillary renal cancer?

    Publicado: 13/2/2021

  2. Episode 81: Noah Hahn discusses front line cisplatin-ineligible PD-L1 data from 361 and 130

    Publicado: 13/2/2021

  3. Episode 80: Results for Darolutamide in non-metastatic CRPC - the Aramis trial

    Publicado: 13/2/2021

  4. Episode 79: Adjuvant nivolumab in operable urothelial cancer

    Publicado: 13/2/2021

  5. Episode 78: Enfortumab Vedotin Special: EV301 randomised trial and EV201 in urothelial cancer

    Publicado: 12/2/2021

  6. Episode 77: The Uromigos Paper of the Month - Nadofaragene for BCG unresponsive NMIBC

    Publicado: 6/2/2021

  7. Episode 76: Tom Hutson discusses lenvatinib and everolimus

    Publicado: 22/1/2021

  8. Episode 75: The Uromigos meet APCCC - bone health and bone disease in prostate cancer with Bertrand Tombal

    Publicado: 14/1/2021

  9. Episode 74: The Uromigos meet APCCC Round 2: First line treatment - low vs high volume; chemo vs abi/enza

    Publicado: 11/1/2021

  10. Episode 73: The Uromigos meet APCCC in a discussion on oligometastatic prostate cancer @APCCC_Lugano

    Publicado: 8/1/2021

  11. Episode 72: Uromigos Christmas Special - Renal cancer year in review

    Publicado: 21/12/2020

  12. Episode 71: Bladder Cancer Uromigos Christmas Special with Matt Galsky

    Publicado: 18/12/2020

  13. Episode 70: The Uromigos Prostate Cancer Christmas Special with Chuck Ryan

    Publicado: 11/12/2020

  14. Episode 69: Testis Cancer Christmas Special: 2020 year in review

    Publicado: 9/12/2020

  15. Episode 68: Uromigos Paper of the Month - a molecular classification of renal cancer in Cancer Cell

    Publicado: 8/12/2020

  16. Episode 67: The Third Uromigos Debate - PD1/VEGF vs PD1/CTLA4 for front line renal cancer

    Publicado: 17/11/2020

  17. Episode 66: Uromigos Paper of the Month - Two papers in Nature Medicine on neoadjuvant immune combinations in bladder cancer

    Publicado: 9/11/2020

  18. Episode 65: Review of the International Kidney Cancer Symposium

    Publicado: 2/11/2020

  19. Episode 64: The Second Uromigos debate with Nobel Laureate Bill Kaelin on new biomarker vs new drugs in RCC

    Publicado: 28/10/2020

  20. Episode 63: The First Uromigos Debate: front line immune therapy vs maintenance avelumab in bladder cancer

    Publicado: 9/10/2020

17 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site